The inhibition of death receptor mediated apoptosis through lysosome stabilization following internalization of carboxyfullerene nanoparticles

Biomaterials

Volumn 32, Issue 16, 2011, Pages 4030-4041

  Li, Wei ^a   Zhao, Lina ^a   Wei, Taotao ^b   Zhao, Yuliang ^a   Chen, Chunying ^a  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Apoptosis; Endocytosis; Fullerene derivative; Hsp 70; Lysosomal membrane

Indexed keywords

APOPTOSIS; ENDOCYTOSIS; FULLERENE DERIVATIVE; HSP 70; LYSOSOMAL MEMBRANES;

CARBOXYLIC ACIDS; DERIVATIVES; FULLERENES; GLYCOPROTEINS; MACROPHAGES; MEMBRANES; MITOCHONDRIA; MOLECULAR BIOLOGY; NANOPARTICLES; OXYGEN; TUMORS;

CELL DEATH;

CATHEPSIN; DEATH RECEPTOR; FULLERENE DERIVATIVE; HEAT SHOCK PROTEIN 70; MALONIC ACID DERIVATIVE; NANOMATERIAL; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; INTERNALIZATION; LYSOSOME; LYSOSOME MEMBRANE; MEMBRANE PERMEABILITY; MEMBRANE STABILIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

APOPTOSIS; BLOTTING, WESTERN; CARBOXYLIC ACIDS; HELA CELLS; HSP72 HEAT-SHOCK PROTEINS; HUMANS; LYSOSOMES; NANOPARTICLES; REACTIVE OXYGEN SPECIES; RECEPTORS, DEATH DOMAIN;

EID: 79953024009     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.02.008     Document Type: Article

References (56)

1. Yudoh K., Shishido K., Murayama H., Yano M., Matsubayashi K., Takada H., et al. Water-soluble C60 fullerene prevents degeneration of articular cartilage in osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development. Arthritis Rheum 2007, 56(10):3307-3318.
2. Fang H., Zhang K., Shen G., Wooley K.L., Taylor J.S. Cationic shell-cross-linked knedel-like (cSCK) nanoparticles for highly efficient PNA delivery. Mol Pharm 2009, 6(2):615-626.
3. Debbage P. Targeted drugs and nanomedicine: present and future. Curr Pharm Des 2009, 15(2):153-172.
4. Liu Y., Jiao F., Qiu Y., Li W., Lao F., Zhou G., et al. The effect of Gd@C82(OH)22 nanoparticles on the release of Th1/Th2 cytokines and induction of TNF-alpha mediated cellular immunity. Biomaterials 2009, 30(23-24):3934-3945.
5. Nielsen G.D., Roursgaard M., Jensen K.A., Poulsen S.S., Larsen S.T. In vivo biology and toxicology of fullerenes and their derivatives. Basic Clin Pharmacol Toxicol 2008, 103(3):197-208.
6. Liang XJ, Meng H, Wang Y, He H, Meng J, Lu J, et al. Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis. Proc Natl Acad Sci U S A 107(16):7449-7454.
7. Bakry R., Vallant R.M., Najam-ul-Haq M., Rainer M., Szabo Z., Huck C.W., et al. Medicinal applications of fullerenes. Int J Nanomedicine 2007, 2(4):639-649.
8. Yin J.J., Lao F., Fu P.P., Wamer W.G., Zhao Y., Wang P.C., et al. The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials. Biomaterials 2009, 30(4):611-621.
9. Li W.P., Liu P., Pilcher B.K., Anderson R.G. Cell-specific targeting of caveolin-1 to caveolae, secretory vesicles, cytoplasm or mitochondria. J Cell Sci 2001, 114(Pt 7):1397-1408.
10. Rade I., Natasa R., Biljana G., Aleksandar D., Borut S. Bioapplication and activity of fullerenol C60(OH)24. Afr J Biotechnol 2008, 7(25):4940-4950.
11. Ali S.S., Hardt J.I., Quick K.L., Kim-Han J.S., Erlanger B.F., Huang T.T., et al. A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties. Free Radic Biol Med 2004, 37(8):1191-1202.
12. Foley S., Crowley C., Smaihi M., Bonfils C., Erlanger B.F., Seta P., et al. Cellular localisation of a water-soluble fullerene derivative. Biochem Biophys Res Commun 2002, 294(1):116-119.
13. Belgorodsky B., Fadeev L., Kolsenik J., Gozin M. Biodelivery of a fullerene derivative. Bioconjug Chem 2007, 18(4):1095-1100.
14. Nel A.E., Madler L., Velegol D., Xia T., Hoek E.M., Somasundaran P., et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 2009, 8(7):543-557.
15. Bolskar R.D., Benedetto A.F., Husebo L.O., Price R.E., Jackson E.F., Wallace S., et al. First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent. J Am Chem Soc 2003, 125(18):5471-5478.
16. Markovic Z., Trajkovic V. Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60). Biomaterials 2008, 29(26):3561-3573.
17. Krusic P.J., Wasserman E., Keizer P.N., Morton J.R., Preston K.F. Radical reactions of C60. Science 1991, 254(5035):1183-1185.
18. Dugan L.L., Lovett E.G., Quick K.L., Lotharius J., Lin T.T., O'Malley K.L. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat Disord 2001, 7(3):243-246.
19. Injac R., Perse M., Cerne M., Potocnik N., Radic N., Govedarica B., et al. Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer. Biomaterials 2009, 30(6):1184-1196.
20. Injac R., Perse M., Obermajer N., Djordjevic-Milic V., Prijatelj M., Djordjevic A., et al. Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas. Biomaterials 2008, 29(24-25):3451-3460.
21. Misirkic M.S., Todorovic-Markovic B.M., Vucicevic L.M., Janjetovic K.D., Jokanovic V.R., Dramicanin M.D., et al. The protection of cells from nitric oxide-mediated apoptotic death by mechanochemically synthesized fullerene C60 nanoparticles. Biomaterials 2009, 30(12):2319-2328.
22. Hu Z., Huang Y., Guan W., Zhang J., Wang F., Zhao L. The protective activities of water-soluble C60 derivatives against nitric oxide-induced cytotoxicity in rat pheochromocytoma cells. Biomaterials 2010, 31(34):8872-8881.
23. Monti D., Moretti L., Salvioli S., Straface E., Malorni W., Pellicciari R., et al. C60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells. Biochem Biophys Res Commun 2000, 277(3):711-717.
24. Li W., Chen C.Y., Ye C., Wei T.T., Zhao Y.L., Lao F., et al. The translocation of fullerenic nanoparticles into lysosome via the pathway of clathrin-mediated endocytosis. Nanotechnology 2008, 19(14):145102-145113.
25. Ye C., Chen C.Y., Chen Z., Meng H., Xing L., Jiang Y.X., et al. In situ observation of C60(C(COOH)2)2 interacting with living cells using fluorescence microscopy. Chin Sci Bull 2006, 51(9):1060-1064.
26. Lao F., Chen L., Li W., Ge C., Qu Y., Sun Q., et al. Fullerene nanoparticles selectively enter oxidation-damaged cerebral microvessel endothelial cells and inhibit JNK-related apoptosis. ACS Nano 2009, 3(11):3358-3368.
27. Lao F., Li W., Han D., Qu Y., Liu Y., Zhao Y.L., et al. Fullerene derivatives protect endothelial cells against NO-induced damage. Nanotechnology 2009, 20(22):225103-225111.
28. Chen G., Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 2002, 296(5573):1634-1635.
29. Ermert M., Pantazis C., Duncker H.R., Grimminger F., Seeger W., Ermert L. In situ localization of TNF alpha/beta, TACE and TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue. Cytokine 2003, 22(3-4):89-100.
30. Tafani M., Cohn J.A., Karpinich N.O., Rothman R.J., Russo M.A., Farber J.L. Regulation of intracellular pH mediates Bax activation in HeLa cells treated with staurosporine or tumor necrosis factor-alpha. J Biol Chem 2002, 277(51):49569-49576.
31. Werneburg N., Guicciardi M.E., Yin X.M., Gores G.J. TNF-alpha-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent. Am J Physiol Gastrointest Liver Physiol 2004, 287(2):436-443.
32. Guicciardi M.E., Deussing J., Miyoshi H., Bronk S.F., Svingen P.A., Peters C., et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 2000, 106(9):1127-1137.
33. Miao Q., Sun Y., Wei T., Zhao X., Zhao K., Yan L., et al. Chymotrypsin B cached in rat liver lysosomes and involved in apoptotic regulation through a mitochondrial pathway. J Biol Chem 2008, 283(13):8218-8228.
34. Feldstein A.E., Werneburg N.W., Li Z., Bronk S.F., Gores G.J. Bax inhibition protects against free fatty acid-induced lysosomal permeabilization. Am J Physiol Gastrointest Liver Physiol 2006, 290(6):G1339-G1346.
35. Feldstein A.E., Werneburg N.W., Canbay A., Guicciardi M.E., Bronk S.F., Rydzewski R., et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 2004, 40(1):185-194.
36. Zhao K., Zhao X., Tu Y., Miao Q., Cao D., Duan W., et al. Lysosomal chymotrypsin B potentiates apoptosis via cleavage of Bid. Cell Mol Life Sci 2010, 67(15):2665-2678.
37. Gyrd-Hansen M., Nylandsted J., Jaattela M. Heat shock protein 70 p.omotes cancer cell viability by safeguarding lysosomal integrity. Cell Cycle 2004, 3(12):1484-1485.
38. Nylandsted J., Gyrd-Hansen M., Danielewicz A., Fehrenbacher N., Lademann U., Hoyer-Hansen M., et al. Heat shock protein 70 p.omotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 2004, 200(4):425-435.
39. Mambula S.S., Calderwood S.K. Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J Immunol 2006, 177(11):7849-7857.
40. Phalen R.F., Oldham M.J., Nel A.E. Tracheobronchial particle dose considerations for in vitro toxicology studies. Toxicol Sci 2006, 92(1):126-132.
41. Antunes F., Cadenas E., Brunk U.T. Apoptosis induced by exposure to a low steady-state concentration of H2O2 is a consequence of lysosomal rupture. Biochem J 2001, 356(Pt 2):549-555.
42. Reers M., Smiley S.T., Mottola-Hartshorn C., Chen A., Lin M., Chen L.B. Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol 1995, 260:406-417.
43. Qu L., Wan J., Cao Y., Zhang Y., Chen R., Huang Y. Analyzing and modeling the inhibitory effect of phosphatidic acid on the GTP-gamma-S binding activity of Goalpha. Proteins 2008, 71(4):1732-1743.
44. Loewen C.J., Gaspar M.L., Jesch S.A., Delon C., Ktistakis N.T., Henry S.A., et al. Phospholipid metabolism regulated by a transcription factor sensing phosphatidic acid. Science 2004, 304(5677):1644-1647.
45. Hamanoue M., Yoshioka A., Ohashi T., Eto Y., Takamatsu K. NF-kappaB prevents TNF-alpha-induced apoptosis in an oligodendrocyte cell line. Neurochem Res 2004, 29(8):1571-1576.
46. Huang Y.L., Shen C.K., Luh T.Y., Yang H.C., Hwang K.C., Chou C.K. Blockage of apoptotic signaling of transforming growth factor-beta in human hepatoma cells by carboxyfullerene. Eur J Biochem 1998, 254(1):38-43.
47. Xia T., Kovochich M., Liong M., Zink J.I., Nel A.E. Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano 2008, 2(1):85-96.
48. Castino R., Demoz M., Isidoro C. Destination 'lysosome': a target organelle for tumour cell killing?. J Mol Recognit 2003, 16(5):337-348.
49. Brunk U.T., Neuzil J., Eaton J.W. Lysosomal involvement in apoptosis. Redox Rep 2001, 6(2):91-97.
50. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998, 94(4):481-490.
51. Wilson J.D., Giesselman B.R., Mitra S., Foster T.H. Lysosome-damage-induced scattering changes coincide with release of cytochrome c. Opt Lett 2007, 32(17):2517-2519.
52. Isobe H., Homma T., Nakamura E. Energetics of water permeation through fullerene membrane. Proc Natl Acad Sci U S A 2007, 104(38):14895-14898.
53. Qiao R., Roberts A.P., Mount A.S., Klaine S.J., Ke P.C. Translocation of C60 and its derivatives across a lipid bilayer. Nano Lett 2007, 7(3):614-619.
54. Xia T., Rome L., Nel A. Nanobiology: particles slip cell security. Nat Mater 2008, 7(7):519-520.
55. Verma A., Uzun O., Hu Y., Hu Y., Han H.S., Watson N., et al. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater 2008, 7(7):588-595.
56. Qiu Y., Liu Y., Wang L., Xu L., Bai R., Ji Y., et al. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 2010, 31(30):7606-7619.